Dermatologists explain which therapies to avoid, which to keep even as they campaign for a regulatory mechanism for ...

Niagen Bioscience can either commercialise the drug candidate independently or sublicense to a strategic pharmaceutical ...

Niagen Bioscience Inc. (NASDAQ:NAGE) saw its stock rise 2% after securing an exclusive global commercial license from Norway’s Haukeland University Hospital to develop its nicotinamide riboside ...

Investing.com -- Niagen Bioscience Inc (NASDAQ: NAGE) stock rose 2% after the company announced an exclusive worldwide commercial license agreement with Norway’s Haukeland University Hospital to ...

Discover how women can embrace longevity and healthy aging through lifestyle choices and targeted supplements that support cellular health, energy, thyroid, gut, and metabolism.

It’s no secret that Amazon is the ultimate hub for all things beauty, from skin-care essentials to daily vitamins, like ...

Easy availability online, self-medication, lack of awareness and social media quackery make for a risky drug cocktail ...

WhatisNAD.net launches a Personalized NAD+ Optimization Platform providing science-based information, customized protocols, and resources about NAD+ benefits for cognitive function, cellular health, ...

Niagen Bioscience Announces First-Ever Peer-Reviewed Study Highlighting the Potential of Nicotinamide Riboside (NR) for Werner Syndrome, a Rare Genetic Disorder Results demonstrated that ...

Werner syndrome trial reveals vitamin B3 derivative nicotinamide riboside boosts NAD+, improving cardiovascular health, skin ulcers and kidney function.